|The genome sequence of the SARS-associated coronavirus|
MA Marra, SJM Jones, CR Astell, RA Holt, A Brooks-Wilson, ...
Science 300 (5624), 1399-1404, 2003
|Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing|
G Robertson, M Hirst, M Bainbridge, M Bilenky, Y Zhao, T Zeng, ...
Nature methods 4 (8), 651, 2007
|Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin|
RD Morin, NA Johnson, TM Severson, AJ Mungall, J An, R Goya, JE Paul, ...
Nature genetics 42 (2), 181, 2010
|The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).|
DS Gerhard, L Wagner, EA Feingold, CM Shenmen, LH Grouse, ...
Genome research 14 (10B), 2121-2127, 2004
|Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts|
S Li, D Shen, J Shao, R Crowder, W Liu, A Prat, X He, S Liu, J Hoog, C Lu, ...
Cell reports 4 (6), 1116-1130, 2013
|Alternative expression analysis by RNA sequencing|
M Griffith, OL Griffith, J Mwenifumbo, R Goya, AS Morrissy, RD Morin, ...
Nature methods 7 (10), 843, 2010
|DGIdb: mining the druggable genome|
M Griffith, OL Griffith, AC Coffman, JV Weible, JF McMichael, NC Spies, ...
Nature methods 10 (12), 1209, 2013
|Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers|
OLMA Griffith, SJMWSM Jones, SM Wiseman
Journal of clinical oncology 24 (31), 5043-5051, 2006
|Convergent loss of PTEN leads to clinical resistance to a PI (3) Kα inhibitor|
D Juric, P Castel, M Griffith, OL Griffith, HH Won, H Ellis, SH Ebbesen, ...
Nature 518 (7538), 240, 2015
|ORegAnno: an open-access community-driven resource for regulatory annotation|
OL Griffith, SB Montgomery, B Bernier, B Chu, K Kasaian, S Aerts, ...
Nucleic acids research 36 (suppl_1), D107-D113, 2007
|SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution|
CA Miller, BS White, ND Dees, M Griffith, JS Welch, OL Griffith, R Vij, ...
PLoS computational biology 10 (8), e1003665, 2014
|Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion|
B Joshi, SS Strugnell, JG Goetz, LD Kojic, ME Cox, OL Griffith, SK Chan, ...
Cancer research 68 (20), 8210-8220, 2008
|Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia|
JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ...
Jama 314 (8), 811-822, 2015
|Modeling precision treatment of breast cancer|
A Daemen, OL Griffith, LM Heiser, NJ Wang, OM Enache, Z Sanborn, ...
Genome biology 14 (10), R110, 2013
|DGIdb 2.0: mining clinically relevant drug–gene interactions|
AH Wagner, AC Coffman, BJ Ainscough, NC Spies, ZL Skidmore, ...
Nucleic acids research 44 (D1), D1036-D1044, 2015
|Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors|
SJM Jones, J Laskin, YY Li, OL Griffith, J An, M Bilenky, YS Butterfield, ...
Genome biology 11 (8), R82, 2010
|CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer|
M Griffith, NC Spies, K Krysiak, JF McMichael, AC Coffman, AM Danos, ...
Nature genetics 49 (2), 170, 2017
|Diagnostic utility of galectin-3 in thyroid cancer|
CG Chiu, SS Strugnell, OL Griffith, SJM Jones, AM Gown, B Walker, ...
The American journal of pathology 176 (5), 2067-2081, 2010
|ORegAnno: an open access database and curation system for literature-derived promoters, transcription factor binding sites and regulatory variation|
SB Montgomery, OL Griffith, MC Sleumer, CM Bergman, M Bilenky, ...
Bioinformatics 22 (5), 637-640, 2006
|Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers|
SK Chan, OL Griffith, IT Tai, SJM Jones
Cancer epidemiology and prevention biomarkers 17 (3), 543-552, 2008